Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection

Jun Meng1, Feng Gu2, Hua Fang2

  • 1Department of Clinical Laboratory, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Rui Jin Er Road, Shanghai 200025, P.R. China.

Journal of Cancer
|February 6, 2019
PubMed

Insights

Serum S100A9 is a valuable prognostic biomarker for hepatocellular carcinoma (HCC) patients post-resection. Elevated S100A9 levels indicate a higher risk of recurrence and poorer survival, aiding in personalized treatment strategies.

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Hepatocellular Carcinoma Research

Background:

  • S100A9 has shown potential as a prognostic biomarker in various cancers, including HCC.
  • Previous research indicates its promise, necessitating further investigation into its specific role in HCC prognosis post-curative resection.

Purpose of the Study:

  • To evaluate the prognostic utility of serum S100A9 levels in predicting outcomes for hepatocellular carcinoma patients following curative resection.
  • To determine if S100A9 can serve as an independent indicator of prognosis in this patient cohort.

Main Methods:

  • A retrospective study involving 379 HCC patients who underwent curative resection.
  • Serum S100A9 levels were measured using ELISA and patients were stratified into training and validation cohorts.
  • Prognostic value was assessed using survival analysis and Cox regression.

Main Results:

  • Significantly higher S100A9 levels were observed in patients with advanced disease and those who experienced recurrence or death.
  • Higher preoperative S100A9 correlated with shorter recurrence-free survival and overall survival in the training cohort.
  • S100A9 was identified as an independent predictor of poor prognosis, with findings validated in a separate cohort.

Conclusions:

  • Serum S100A9 is significantly associated with adverse outcomes in HCC patients after resection.
  • S100A9 can function as a novel and independent prognostic biomarker for hepatocellular carcinoma.
  • Measuring S100A9 may assist in tailoring treatment plans to improve patient prognosis.

Related Concept Videos

Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.0K
Elevation of Intermediate Points on Vertical Curves01:20

Elevation of Intermediate Points on Vertical Curves

Vertical curves are essential in roadway design because they provide smooth transitions between varying roadway grades. Designing vertical curves involves calculating intermediate elevations and identifying the curve's highest or lowest point, which is essential for optimal roadway performance.Intermediate elevations on a vertical curve are determined using the tangent offset method. This method considers the initial elevation at the start of the curve, the grades, and the curve's geometry. The...
288
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
852
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
435
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
619
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
217